Apr
12
2023
On demand
Large-scale production of hiPSCs in automated bioreactors to produce wholly-cellular bioinks for tissue engineering
Wednesday 08:00 PDT / 11:00 EDT / 16:00 BST / 17:00 CEST
Sponsor
Culturing human induced pluripotent stem cells (hiPSCs) suitable for bioprinting applications requires billions of cells, which can differentiate into the desired cell types for tissue engineering. It is challenging to select optimal, reproducible, and scalable process conditions, and culture media, for generating high-yield, functional hiPSCs.
In this webinar, Mark Skylar-Scott, Ph.D., Assistant Professor of Bioengineering at Stanford, and Debbie L. Ho, Basic Life Science Researcher at Stanford, showcase an optimized culture-to-3D bioprinting pipeline for billion cell-scale tissue engineering.
Watch now to:
- Learn more about how bioprinting can increase the availability of organs
- Explore alternatives to using 2-D flask cultures to generate required cell quantities
- Understand how a DoE approach can create efficiencies in your culture process
- Learn strategies to maintain hiPSC pluripotency at various bioreactor scales
SPEAKERS
You might also like
Same-section spatial multiomics: a platform for detailed analysis of the solid tumor TME
Emily Neil, Ariadna Pascual
27 June
in 69
Days
Pure and simple: understanding LNP analytics for better mRNA-based drugs
Adam Crowe
29 May
in 40
Days
Empowering patient care: in-process and quality control solutions for cellular therapies
Christin Tischner, Simon Lennartz
23 May
in 34
Days
T cells from beginning to end: optimizing leukopak and drug product cryopreservation
Meredith Safford, ShaNelle Yelity
22 May
in 33
Days
Mastering AAV production: best practices For small- to large-scale manufacturing success and reduced development time
Emily Jackson-Holmes
21 May
in 32
Days